Dose finding study of high-dose epirubicin (E) and docetaxel (D) as first-line chemotherapy in advanced breast cancer (ABC)

被引：0
|
作者：
Pagani, O [1 ]
Sessa, C [1 ]
Martinelli, G [1 ]
Crivellari, D [1 ]
Goldhirsch, A [1 ]
机构：
[1] Int Breast Canc Study Grp, Bern, Switzerland
来源：
EUROPEAN JOURNAL OF CANCER | 1998年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OP37
引用
收藏
页码：S7 / S7
页数：1
相关论文
共 50 条
  • [21] Induction preoperative chemotherapy with high-dose epirubicin in locally advanced breast cancer (LABC)
    Silvestro, P
    DAiuto, G
    Caparrotti, G
    Menditto, C
    Tambaro, R
    Rinaldi, L
    Pergola, M
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 713 - 713
  • [22] Phase I intrapatient dose escalation study of weekly epirubicin and docetaxel as first line chemotherapy in metastatic breast cancer
    Lo, N.
    Ayers, S.
    Catell, E.
    Koetzl, B.
    Singh, N.
    Alexander, G.
    Lowe, F.
    Rea, D. W.
    EJC SUPPLEMENTS, 2004, 2 (03): : 133 - 133
  • [23] Phase I study of docetaxel (D) in combination with epirubicin (E) as first line chemotherapy in metastatic breast cancer
    Borquez, D
    Raab, G
    Harstrick, A
    Wilke, HJ
    Achterrath, W
    Eiermann, W
    Seeber, S
    ANNALS OF ONCOLOGY, 1998, 9 : 29 - 29
  • [24] Combination of docetaxel, epirubicin and vinorelbine administered every 2 weeks as first-line therapy in patients with metastatic breast cancer:: a dose-finding study
    Esteban, E
    Modollel, A
    de Sande, LG
    Palacio, I
    Muñiz, I
    Fernández, Y
    Corral, N
    Fra, J
    Sala, M
    Vieitez, JM
    Estrada, E
    Lacave, AJ
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 80 (03) : 257 - 265
  • [25] Combination of Docetaxel, Epirubicin and Vinorelbine Administered Every 2 Weeks as First-line Therapy in Patients with Metastatic Breast Cancer: A Dose-finding Study
    Emilio Esteban
    Antonio Modollel
    Luis González de Sande
    Isabel Palacio
    Isabel Muñiz
    Yolanda Fernández
    Norberto Corral
    Joaquin Fra
    Marian Sala
    Jose María Vieitez
    Enrique Estrada
    AJ Lacave
    Breast Cancer Research and Treatment, 2003, 80 : 257 - 265
  • [26] Dose Finding Study of Carboplatin in First Line Chemotherapy in Advanced Ovarian Cancer
    Uriol, E.
    Fonseca, P. J.
    Villanueva, N.
    Coto, P.
    Izquierdo, M.
    Vieitez, J. M.
    Esteban, E.
    Lacave, A. J.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S541 - S541
  • [27] Randomised study of high-dose epirubicin versus high-dose epirubicin-cisplatin chemotherapy for advanced soft tissue sarcoma
    Jelic, S
    Kovcin, V
    Milanovic, N
    Babovic, N
    Kreacic, M
    Ristovic, Z
    Vlajic, M
    FilipovicLjeskovic, I
    EUROPEAN JOURNAL OF CANCER, 1997, 33 (02) : 220 - 225
  • [28] Secondary leukemia after first-line high-dose chemotherapy for patients with advanced germ cell cancer
    Wierecky, J
    Kollmannsberger, C
    Boehlke, I
    Kuczyk, M
    Schleicher, J
    Schleucher, N
    Metzner, B
    Kanz, L
    Hartmann, J
    Bokemeyer, C
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2005, 131 (04) : 255 - 260
  • [29] Secondary leukemia after first-line high-dose chemotherapy for patients with advanced germ cell cancer
    J. Wierecky
    C. Kollmannsberger
    I. Boehlke
    M. Kuczyk
    J. Schleicher
    N. Schleucher
    B. Metzner
    L. Kanz
    J. T. Hartmann
    C. Bokemeyer
    Journal of Cancer Research and Clinical Oncology, 2005, 131 : 255 - 260
  • [30] High-dose epirubicin plus docetaxel in locally advanced breast cancer (LABC). An ONCOPAZ and associated hospitals study.
    Milla, A
    Morales, S
    Burillo, MA
    Borrega, P
    Machenes, I
    Checa, T
    Janariz, J
    Illaramendi, JJ
    Lizon, J
    Gonzalez-Baron, M
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (03) : 271 - 271
12345